Publication | Closed Access

Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial

HypertensionHeart FailureInvasive SystemCardiovascular DiseaseAntihypertensive TherapyBlood Pressure ControlPharmacotherapyBaroreflex Activation TherapyAnesthesiaMedicineCardiologyBlood PressureNeuromuscular Blockade